Live Breaking News & Updates on Hedge Funds Weigh In On Paratek Pharmaceuticals

Stay updated with breaking news from Hedge funds weigh in on paratek pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Paratek Pharmaceuticals (NASDAQ:PRTK) Upgraded at StockNews.com

StockNews.com upgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a hold rating to a buy rating in a report issued on Tuesday. A number of other research firms have also weighed in on PRTK. BTIG Research cut their price objective on shares of Paratek Pharmaceuticals from $24.00 to $5.00 in a research note […] ....

Jamesd Dondero , Hedge Funds Weigh In On Paratek Pharmaceuticals , News Ratings For Paratek Pharmaceuticals Daily , Paratek Pharmaceuticals Company Profile , Commonwealth Equity Services , Paratek Pharmaceuticals Inc , Cutter Co Brokerage Inc , Paratek Pharmaceuticals Stock Performance , Paratek Pharmaceuticals , Securities Exchange Commission , Ci Private Wealth , Get Rating , Exchange Commission , Equity Services , Exoduspoint Capital Management , Paratek Pharmaceuticals Daily , Nasdaq Prtk , Stocknews Com ,

Paratek Pharmaceuticals (NASDAQ:PRTK) Upgraded by StockNews.com to "Buy"

Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. A number of other equities research analysts have also recently commented on PRTK. HC Wainwright dropped their price objective on shares of Paratek […] ....

Jamesd Dondero , Cm Management , Paratek Pharmaceuticals Inc , Paratek Pharmaceuticals Trading , Paratek Pharmaceuticals Company Profile , Arete Wealth Advisors , News Ratings For Paratek Pharmaceuticals Daily , Kathmere Capital Management , Prospera Financial Services Inc , Paratek Pharmaceuticals , Securities Exchange Commission , Insider Activity At Paratek Pharmaceuticals , Hedge Funds Weigh In On Paratek Pharmaceuticals , Get Rating , Exchange Commission , Wealth Advisors , Capital Management , Financial Services Inc , Paratek Pharmaceuticals Daily , Nasdaq Prtk , Stocknews Com ,

BTIG Research Trims Paratek Pharmaceuticals (NASDAQ:PRTK) Target Price to $5.00

Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) had its target price trimmed by BTIG Research from $24.00 to $5.00 in a research report sent to investors on Tuesday morning, The Fly reports. A number of other analysts have also issued reports on PRTK. HC Wainwright lowered their price target on Paratek Pharmaceuticals from $20.00 to $10.00 […] ....

Jamesd Dondero , News Ratings For Paratek Pharmaceuticals Daily , Cutter Co Brokerage Inc , Hedge Funds Weigh In On Paratek Pharmaceuticals , Ci Private Wealth , Securities Exchange Commission , Paratek Pharmaceuticals Stock Performance , Paratek Pharmaceuticals , Commonwealth Equity Services , Paratek Pharmaceuticals Inc , Prospera Financial Services Inc , Get Rating , Exchange Commission , Financial Services Inc , Paratek Pharmaceuticals Daily , Nasdaq Prtk , Lower Price Target , Btig Research ,

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Major Shareholder Buys $147,191.80 in Stock

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) major shareholder James D. Dondero purchased 105,137 shares of the firm’s stock in a transaction on Monday, March 20th. The stock was bought at an average price of $1.40 per share, for a total transaction of $147,191.80. Following the completion of the transaction, the insider now directly owns […] ....

Jamesd Dondero , News Ratings For Paratek Pharmaceuticals Daily , Ci Private Wealth , Commonwealth Equity Services , Hedge Funds Weigh In On Paratek Pharmaceuticals , Paratek Pharmaceuticals , Paratek Pharmaceuticals Price Performance , Quarter For Paratek Pharmaceuticals , Prospera Financial Services Inc , Paratek Pharmaceuticals Inc , Get Rating , Financial Services Inc , Equity Services , Point Capital Management , Jane Street Group , Paratek Pharmaceuticals Daily , Nasdaq Prtk , Insider Trading , Nsider Trades ,

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Major Shareholder Buys $187,620.00 in Stock

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) major shareholder James D. Dondero bought 106,000 shares of the business’s stock in a transaction on Wednesday, March 22nd. The shares were acquired at an average cost of $1.77 per share, for a total transaction of $187,620.00. Following the purchase, the insider now directly owns 2,056,000 shares in […] ....

Jamesd Dondero , Paratek Pharmaceuticals , Prospera Financial Services Inc , Paratek Pharmaceuticals Price Performance , News Ratings For Paratek Pharmaceuticals Daily , Quarter For Paratek Pharmaceuticals , Securities Exchange Commission , Commonwealth Equity Services , Hedge Funds Weigh In On Paratek Pharmaceuticals , Ci Private Wealth , Paratek Pharmaceuticals Inc , Get Rating , Exchange Commission , Financial Services Inc , Equity Services , Point Capital Management , Jane Street Group , Paratek Pharmaceuticals Daily , Nasdaq Prtk , Insider Trading , Nsider Trades ,